Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron

The emergence of SARS-CoV-2 variants that escape from immune neutralization are challenging vaccines and antibodies developed to stop the COVID-19 pandemic. Thus, it is important to establish therapeutics directed toward multiple or specific SARS-CoV-2 variants. The envelope spike (S) glycoprotein o...

Descripción completa

Detalles Bibliográficos
Autores principales: Casasnovas, José M., Margolles, Yago, Noriega, María A., Guzmán, María, Arranz, Rocío, Melero, Roberto, Casanova, Mercedes, Corbera, Juan Alberto, Jiménez-de-Oya, Nereida, Gastaminza, Pablo, Garaigorta, Urtzi, Saiz, Juan Carlos, Martín-Acebes, Miguel Ángel, Fernández, Luis Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082315/
https://www.ncbi.nlm.nih.gov/pubmed/35547740
http://dx.doi.org/10.3389/fimmu.2022.863831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082315/
https://www.ncbi.nlm.nih.gov/pubmed/35547740
http://dx.doi.org/10.3389/fimmu.2022.863831

Ejemplares similares